1 – 10 of 68
      - show: 10
- |
- sort: year (new to old)
        Close
        
            
    
    Embed this list
<iframe src=""
              width=""
              height=""
              allowtransparency="true"
              frameborder="0">
            </iframe>
        - 2025
- 
                        Mark
        An online national quality assessment survey of prostate MRI reading : interreader variability in prostate volume measurement and PI-RADS classification
    
    - Contribution to journal › Article
 
- 
                        Mark
        Association of height, BMI, and smoking status with prostate cancer risk before and after the introduction of PSA testing in Sweden
    
    - Contribution to journal › Article
 
- 2024
- 
                        Mark
        A pilot study of AI-assisted reading of prostate MRI in Organized Prostate Cancer Testing
    
    - Contribution to journal › Article
 
- 2023
- 
                        Mark
        Unanswered questions in prostate cancer — findings of an international multi-stakeholder consensus by the PIONEER consortium
    
    - Contribution to journal › Article
 
- 
                        Mark
        How Well do Polygenic Risk Scores Identify Men at High Risk for Prostate Cancer? Systematic Review and Meta-Analysis
    
    - Contribution to journal › Article
 
- 
                        Mark
        Long-term Risks of Depression and Suicide Among Men with Prostate Cancer : A National Cohort Study
    
    - Contribution to journal › Article
 
- 
                        Mark
        Prediagnostic markers of insulin resistance and prostate cancer risk and death : A pooled study
    
    - Contribution to journal › Article
 
- 2022
- 
                        Mark
        Liproca Depot : A New Antiandrogen Treatment for Active Surveillance Patients
    
    - Contribution to journal › Article
 
- 
                        Mark
        The 5-Hydroxymethylcytosine Landscape of Prostate Cancer
    
    - Contribution to journal › Article
 
- 
                        Mark
        Results from 22 years of Followup in the Göteborg Randomized Population-Based Prostate Cancer Screening Trial
    
    - Contribution to journal › Article
 
